In studies of EGFR expression in bladder cancer EGFR overexpression varied strongly between 27 to 74% [17–19], which may be due in part to heterogeneous cohorts and different histopathological and molecular subtypes [20]. This evidence concerns the gene EGFR and urinary bladder carcinoma.